Pfizer Posts First Quarterly Revenue Growth Since Peak COVID Vaccine Sales

Key TakeawaysPfizer raised the midpoint of its full-year revenue and adjusted earnings per share (EPS) guidance.The company posted its first quarter of year-over-year revenue growth since the fourth quarter of 2022, when COVID vaccine and medication revenue peaked.Pfizer also said it launched a manufacturing optimization program that it projects will save $1.5 billion by the end of 2027. Pfizer (PFE) shares rose Tuesday after the pharmaceutical giant beat second-quarter revenue expectations and raised its f ...